Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bert Boer"'
Autor:
Joost J. Enzing, Frédérique C. W. van Krugten, Iryna Sabat, Sebastian Neumann-Böhme, Bert Boer, Saskia Knies, Werner B. F. Brouwer, ECOS consortium
Publikováno v:
Health and Quality of Life Outcomes, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Introduction To make efficient use of available resources, decision-makers in healthcare may assess the costs and (health) benefits of health interventions. For interventions aimed at improving mental health capturing the full health benefit
Externí odkaz:
https://doaj.org/article/d24839b8cf99460eb75129fa87e0a64f
Autor:
Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer, Werner B. F. Brouwer
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Introduction Drug reimbursement decisions are often made based on a price set by the manufacturer. In some cases, this price leads to public and scientific debates about whether its level can be justified in relation to its costs, including
Externí odkaz:
https://doaj.org/article/7a43d19d39c6441bbadfd1fdfdf97ada
Autor:
Tineke Kleinhout-Vliek, Antoinette de Bont, Meindert Boysen, Matthias Perleth, Romke van der Veen, Jacqueline Zwaap, Bert Boer
Publikováno v:
International Journal of Health Policy and Management, Vol 9, Iss 9, Pp 390-402 (2020)
Background Across Western Europe, procedures and formalised criteria for taking decisions on the coverage (inclusion in the benefits basket or equivalent) of healthcare technologies vary substantially. In the decision documents, which display the jus
Externí odkaz:
https://doaj.org/article/3d5311d68e7145cca3837b23afbb16a9
Publikováno v:
International Journal of Health Policy and Management, Vol 6, Iss 1, Pp 43-47 (2017)
Embedding health technology assessment (HTA) in a fair process has great potential to capture societal values relevant to public reimbursement decisions on health technologies. However, the development of such processes for priority setting has large
Externí odkaz:
https://doaj.org/article/7985e1a9e1fd4b5c999cf9629643b358
Publikováno v:
Health Economics, Policy and Law, 16(4), 440-456. Cambridge University Press
Health Economics, Policy, and Law
Health Economics, Policy, and Law
Currently, reimbursement decisions based on health technology assessments (HTA) in the Netherlands mostly concern outpatient pharmaceuticals. The Dutch government aspires to broaden the systematic application of full HTA towards other types of health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::403d591119a48017291efdc3ea29860d
https://hdl.handle.net/1765/130016
https://hdl.handle.net/1765/130016
Publikováno v:
Health Policy and Technology, 10(1), 111-119. Fellowship of Postgraduate Medicine
IntroductionMost collectively funded healthcare systems set limits to their benefit package. Doing so requires judgements which may involve economic evaluations. Performing such evaluations brings methodological challenges, which may be more pronounc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de6769f93b3199759d78ca56ace0f87
https://doi.org/10.1016/j.hlpt.2020.09.006
https://doi.org/10.1016/j.hlpt.2020.09.006
Autor:
Wieteke van Dijk, Jacqueline Zwaap, Rob Baltussen, Jan-Kees Helderman, Bert Boer, Leon Bijlmakers, Job van Exel, Maarten Jansen, Stef Groenewoud
Publikováno v:
Value in Health, 23, 1, pp. 32-38
Value in Health, 23, 32-38
Value in Health, 23, 32-38
Background: Some studies in the Netherlands have gauged public views on principles for health care priority setting, but they fall short of comprehensively explaining the public disapproval of several recent reimbursement decisions. Objective: To obt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fb3d3fb9ace576ffbc54baacfe6682
https://doi.org/10.1016/j.jval.2019.07.015
https://doi.org/10.1016/j.jval.2019.07.015
Publikováno v:
Health Policy, 121(7), 731-744. Elsevier Ireland Ltd
Context Policy makers and insurance companies decide on coverage of care by both calculating (cost-) effectiveness and assessing the necessity of coverage. Aim To investigate argumentations pertaining to necessity used in coverage decisions made by p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf929c68bcf3e16c82fbc1858d9cfa7
https://doi.org/10.1016/j.healthpol.2017.04.011
https://doi.org/10.1016/j.healthpol.2017.04.011
Publikováno v:
International Journal of Health Policy and Management, 6, 1, pp. 43-47
International Journal of Health Policy and Management
International Journal of Health Policy and Management, Vol 6, Iss 1, Pp 43-47 (2017)
International Journal of Health Policy and Management, 6, 43-47
International Journal of Health Policy and Management
International Journal of Health Policy and Management, Vol 6, Iss 1, Pp 43-47 (2017)
International Journal of Health Policy and Management, 6, 43-47
Contains fulltext : 173677.pdf (Publisher’s version ) (Open Access) Embedding health technology assessment (HTA) in a fair process has great potential to capture societal values relevant to public reimbursement decisions on health technologies. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fab0cf51b6f07a0ee06b845d1a2f6a9
https://hdl.handle.net/2066/166628
https://hdl.handle.net/2066/166628
Autor:
J.A. van Til, Bert Boer, Maarten Joost IJzerman, Rob Baltussen, Catharina G.M. Groothuis-Oudshoorn, Jacqueline Zwaap
Publikováno v:
Value in health, 19(7), A469-A470. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93576835ce3fe68c0e637711046655c6
https://doi.org/10.1016/j.jval.2016.09.715
https://doi.org/10.1016/j.jval.2016.09.715